細胞・遺伝子の調査レビュー：2024年

世界の細胞・遺伝子治療ツールおよび試薬の市場規模は、2024年の100億米ドルから、予測期間中は10.8%のCAGRで推移し、2029年には167億米ドルに成長すると予測されています。

世界の細胞治療バイオ製造の市場規模は、2024年の97億米ドルから、予測期間中はCAGR 11.5%で推移し、2029年末には167億米ドルに達すると予測されています。

世界の遺伝子合成の市場規模は、2023年の20億米ドルから、予測期間中はCAGR15.8%で推移し、2028年には41億米ドルに達すると予測されています。

細胞および遺伝子治療は、細胞や遺伝子を用いて疾患の治療を目的とする研究、開発、製造、流通を含む広範な産業です。細胞や遺伝子は、前臨床試験、臨床試験、治療薬の製造、ウイルスベクター、改変細胞、個別化医療など、さまざまな分野で活用されています。

この市場の成長を促す主な要因の一つは、投資や資金提供の増加です。新たな細胞・遺伝子治療の研究開発が急速に進み、これまでにないレベルのイノベーションがもたらされていることも、市場成長を後押ししています。一方で、これらの治療法の開発コストが非常に高いことが、市場の成長を抑制する要因となっています。

当調査レビューは、BCC Researchが2024年に発行した細胞・遺伝子治療ツールおよび試薬、細胞治療バイオ製造、遺伝子合成、自動化・閉鎖型細胞療法、細胞・遺伝子治療、生細胞イメージング、シングルセル技術に関するレポートのハイライトと抜粋を含み、それぞれの市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析などをまとめています。

目次

第1章 序文

第2章 細胞・遺伝子治療ツールおよび試薬：世界市場 (BIO208C)

• 調査範囲
• 市場サマリー
• 市場概要
• 承認された細胞・遺伝子治療製品
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 市場セグメンテーション分析
• セグメント別内訳
• 世界の細胞・遺伝子治療ツールおよび試薬市場：製品別
• 免疫測定
• バイオリアクター
• 白血球除去療法
• GMP抗体
• マルチプレックス免疫測定
• ベクトル
• 細胞分離
• 凍結保存
• 細胞増殖
• メディア
• GMPタンパク質
• GMP小分子
• CRSモニタリング
• 世界の細胞・遺伝子治療ツールおよび試薬市場：用途別
• 癌
• 希少疾患
• その他の病気
• 世界の細胞・遺伝子治療ツールおよび試薬市場：エンドユーザー別
• 製薬およびバイオテクノロジー企業
• 学術研究機関
• 臨床ラボ
• 地理的内訳
• 世界の細胞・遺伝子治療ツールおよび試薬市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域
• 新興技術と開発
• 閉鎖型および自動化システム
• 使い捨て技術
• 細胞・遺伝子治療ツールおよび試薬市場における持続可能性：ESGの観点
• ESG：イントロダクション
• 業界におけるESGのパフォーマンス
• 業界におけるESGの実践
• 環境パフォーマンス
• 社会的パフォーマンス
• ガバナンスパフォーマンス
• BCCによる総論

第3章 細胞治療バイオ製造：世界市場 (BIO211B)

• 調査範囲
• 市場サマリー
• 市場概要
• 市場力学
• 概要
• 市場促進要因
• 市場抑制要因
• 市場機会
• 細胞治療バイオ製造の市場セグメンテーション分析
• 主要な市場動向
• 世界の細胞治療バイオ製造市場
• 細胞治療バイオ製造のセグメンテーション内訳
• 世界の細胞治療バイオ製造市場：製品タイプ別
• 世界の細胞治療バイオ製造市場：用途別
• 骨格筋の修復
• 骨の修復
• 癌
• 心血管疾患
• 神経疾患
• その他
• 細胞治療バイオ製造の地理的内訳
• 世界の細胞治療バイオ製造市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第4章 遺伝子合成：各種技術と世界市場 (BIO251A)

• レポートの範囲
• 市場サマリー
• 市場概要
• 遺伝子合成の概要
• 市場力学
• 概要
• 市場促進要因
• 抑制要因
• 機会
• 課題
• 遺伝子合成のセグメンテーションの内訳
• 遺伝子合成：世界市場
• 世界の遺伝子合成市場：手法別
• 固相合成
• PCRベースの酵素合成
• チップベース合成
• 世界の遺伝子合成市場：サービス別
• 抗体DNA合成
• ウイルスDNA合成
• その他
• 世界の遺伝子合成市場：用途別
• 遺伝子・細胞治療開発
• ワクチン開発
• 病気診断
• その他
• 世界の遺伝子合成市場：エンドユーザー別
• 学術機関および政府研究機関
• バイオテクノロジーおよび製薬会社
• CRO
• 遺伝子合成の地理的内訳
• 社内かアウトソーシングか
• コストに関する考慮事項
• 品質管理と保証
• 利便性と納期
• カスタマイズと特化
• 戦略的考慮事項
• 遺伝子合成のM&Aとベンチャーファンディング
• サマリー

第5章 世界の自動化・閉鎖型細胞療法市場 (BIO258A)

• レポート範囲
• 市場洞察
• 市場概要
• 概要
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 自動化・閉鎖型細胞療法のセグメンテーション内訳
• 世界の自動化・閉鎖型細胞療法市場：自動化タイプ別
• 半自動細胞療法
• 完全自動化細胞療法
• 世界の自動化・閉鎖型細胞療法市場：細胞タイプ別
• CAR-T細胞
• 幹細胞
• その他
• 世界の自動化・閉鎖型細胞療法市場：用途別
• 市場規模・予測
• 臨床
• 市販
• 世界の自動化・閉鎖型細胞療法市場の地理的内訳
• 世界の自動化・閉鎖型細胞療法市場：地域別
• 市場規模・予測
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 細胞・遺伝子治療の世界市場 (BIO225B)

• 調査範囲
• 市場サマリー
• 市場価値
• 市場概要
• 細胞・遺伝子治療の概要
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 細胞・遺伝子治療のセグメンテーション内訳
• 世界の細胞・遺伝子治療市場
• 市場分析
• 細胞療法
• 市場規模・予測
• 遺伝子組み換え細胞療法
• 市場規模・予測
• 遺伝子治療
• 市場予測
• 遺伝子改変細胞療法および遺伝子療法で使用されるベクター
• 市場分析
• アデノ随伴ウイルスベクター
• レトロウイルスベクター
• レンチウイルスベクター
• 遺伝子治療で使用されるその他のベクター
• 市場内訳：医薬品別
• Zolgensma
• Yescarta
• Kymriah
• Abecma
• Maci
• Tecartus
• Epicel
• その他
• 市場内訳：用途別
• 腫瘍
• 希少疾患
• 眼科
• その他
• 細胞・遺伝子治療の地理的内訳
• 市場内訳：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 世界の生細胞イメージング市場 (BIO256A)

• レポート範囲
• 市場サマリー
• 市場概要
• 概要
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 市場の課題
• 生細胞イメージングのセグメンテーションの内訳
• 生細胞イメージング市場の内訳：コンポーネント別
• 機器・ソフトウェア
• 消耗品
• サービス
• 生細胞イメージング市場の内訳：技術別
• タイムラプス顕微鏡
• 蛍光共鳴エネルギー移動 (FRET)
• 蛍光漂白後回復 (FRAP)
• ハイコンテントスクリーニング (HCS)
• その他
• 生細胞イメージング市場の内訳：エンドユーザー別
• 製薬およびバイオテクノロジー企業
• 学術研究機関
• CRO
• 生細胞イメージング市場の内訳：地理的内訳
• 北米
• 欧州
• アジア太平洋
• その他

第8章 世界のシングルセル技術市場 (BIO257A)

• レポート範囲
• 市場サマリー
• 市場概要
• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 市場の課題
• シングルセル技術のセグメント別内訳
• シングルセル技術市場の分析：製品別
• 消耗品
• 機器
• シングルセル技術市場の分析：細胞タイプ別
• ヒト細胞
• 動物細胞
• 微生物細胞
• 技術別市場内訳
• フローサイトメトリー
• 次世代シーケンシング
• ポリメラーゼ連鎖反応
• 顕微鏡検査
• 質量分析
• その他
• シングルセル技術市場の分析：用途別
• 研究
• 医療
• シングルセル技術市場の分析：エンドユーザー別
• 調査・学術研究所
• バイオテクノロジー・製薬会社
• 病院・診断ラボ
• 細胞バンク・体外受精センター
• シングルセル技術の地理的内訳
• シングルセル技術市場の分析：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第9章 付録

List of Tables

• Table 1 : Global Market for CGT Tools and Reagents, by Application, Through 2029
• Table 2 : Global Market for CGT Tools and Reagents, by Region, Through 2029
• Table 3 : Approved CGT Products, as of 2024
• Table 4 : Global Cancer Statistics, 2022
• Table 5 : Global Market for CGT Tools and Reagents, by Product, Through 2029
• Table 6 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
• Table 7 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
• Table 8 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
• Table 9 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
• Table 10 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
• Table 11 : Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
• Table 12 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
• Table 13 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
• Table 14 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
• Table 15 : Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
• Table 16 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
• Table 17 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
• Table 18 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
• Table 19 : Global Market for CGT Tools and Reagents, by Application, Through 2029
• Table 20 : Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
• Table 21 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
• Table 22 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
• Table 23 : Global Market for CGT Tools and Reagents, by End User, Through 2029
• Table 24 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
• Table 25 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
• Table 26 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
• Table 27 : Global Market for CGT Tools and Reagents, by Region, Through 2029
• Table 28 : North American Market for CGT Tools and Reagents, by Product, Through 2029
• Table 29 : North American Market for CGT Tools and Reagents, by Application, Through 2029
• Table 30 : North American Market for CGT Tools and Reagents, by End User, Through 2029
• Table 31 : European Research Initiatives Focused on Personalized Medicine
• Table 32 : European Market for CGT Tools and Reagents, by Product, Through 2029
• Table 33 : European Market for CGT Tools and Reagents, by Application, Through 2029
• Table 34 : European Market for CGT Tools and Reagents, by End User, Through 2029
• Table 35 : Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
• Table 36 : Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
• Table 37 : Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
• Table 38 : RoW Market for CGT Tools and Reagents, by Product, Through 2029
• Table 39 : RoW Market for CGT Tools and Reagents, by Application, Through 2029
• Table 40 : RoW Market for CGT Tools and Reagents, by End User, Through 2029
• Table 41 : Focus Areas in ESG Metrics
• Table 42 : Environmental Performance Initiatives in the CGT Tool and Reagent Market
• Table 43 : Social Performance Initiatives in the CGT Tool and Reagent Market
• Table 44 : Governance Performance Initiatives in the CGT Tool and Reagent Market
• Table 45 : ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
• Table 46 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
• Table 47 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
• Table 48 : Global Market for Cell Therapy Biomanufacturing, Through 2029
• Table 49 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
• Table 50 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
• Table 51 : Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
• Table 52 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
• Table 53 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
• Table 54 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
• Table 55 : Global Market for Gene Synthesis, Through 2028
• Table 56 : Global Market for Gene Synthesis, by Services, Through 2028
• Table 57 : Global Market for Gene Synthesis, Through 2028
• Table 58 : Global Market for Gene Synthesis, by Method, Through 2028
• Table 59 : Global Market for Solid-phase Synthesis, by Region, Through 2028
• Table 60 : Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
• Table 61 : Global Market for Chip-based Synthesis, by Region, Through 2028
• Table 62 : Global Market for Gene Synthesis, by Services, Through 2028
• Table 63 : Global Market for Antibody DNA Synthesis, by Region, Through 2028
• Table 64 : Global Market for Viral DNA Synthesis, by Region, Through 2028
• Table 65 : Global Market for Other Synthesis Services, by Region, Through 2028
• Table 66 : Global Market for Gene Synthesis, by Application, Through 2028
• Table 67 : Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
• Table 68 : Global Market for Vaccine Development Applications, by Region, Through 2028
• Table 69 : Global Market for Disease Diagnosis Applications, by Region, Through 2028
• Table 70 : Global Market for Other Applications, by Region, Through 2028
• Table 71 : Global Market for Gene Synthesis, by End User, Through 2028
• Table 72 : Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
• Table 73 : Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
• Table 74 : Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
• Table 75 : Mergers and Acquisitions (M&A), 2021-2023
• Table 76 : Venture Funding, 2022 and 2023
• Table 77 : Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
• Table 78 : Differences between Semi-Automation and Full Automation in Cell Therapy
• Table 79 : Global Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 80 : Select Semi-Automated Cell Therapy Systems
• Table 81 : Global Market for Semi-Automated Cell Therapy, by Region, Through 2029
• Table 82 : Global Market for Semi-Automated Cell Therapy, by Workflow, Through 2029
• Table 83 : Global Market for Automated and Closed Apheresis, by Region, Through 2029
• Table 84 : Global Market for Automated and Closed Expansion, by Region, Through 2029
• Table 85 : Global Market for Automated and Closed Fill-Finish, by Region, Through 2029
• Table 86 : Global Market for Automated and Closed Separation, by Region, Through 2029
• Table 87 : Global Market for Other Automated and Closed Workflows, by Region, Through 2029
• Table 88 : Global Market for Fully Automated Cell Therapy, by Region, Through 2029
• Table 89 : Global Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 90 : FDA-Approved CAR-T Cell Therapies
• Table 91 : Global Market for Automated and Closed CAR-T Cell Therapy, by Region, Through 2029
• Table 92 : Global Market for Automated and Closed Stem Cell Therapy, by Region, Through 2029
• Table 93 : Global Market for Automated and Closed Other Cell Therapies, by Region, Through 2029
• Table 94 : Global Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 95 : Global Market for Clinical Automated and Closed Cell Therapy, by Region, Through 2029
• Table 96 : Global Market for Commercial Automated and Closed Cell Therapy, by Region, Through 2029
• Table 97 : Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
• Table 98 : North American Market for Automated and Closed Cell Therapy, by Country, Through 2029
• Table 99 : North American Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 100 : North American Market for Semi-automated Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 101 : North American Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 102 : North American Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 103 : European Market for Automated and Closed Cell Therapy, by Country, Through 2029
• Table 104 : European Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 105 : European Market for Semi-Automated Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 106 : European Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 107 : European Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 108 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Country, Through 2029
• Table 109 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 110 : Asia-Pacific Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 111 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 112 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 113 : RoW Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 114 : RoW Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 115 : RoW Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 116 : RoW Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 117 : Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
• Table 118 : Number of New Cases and Deaths Due to Various Cancers Globally, 2020
• Table 119 : Comparison of Accelerated Approvals for Various Drugs
• Table 120 : Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
• Table 121 : Global Market for Cell Therapy, by Region, Through 2028
• Table 122 : Approved CAR-T Products, as of December 2023
• Table 123 : Global Market for Gene-modified Cell Therapy, by Region, Through 2028
• Table 124 : Global Market for Gene Therapy, by Region, Through 2028
• Table 125 : Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, Through 2028
• Table 126 : Global Market for Cell and Gene Therapy, by Drug Product, Through 2028
• Table 127 : Global Market for Cell and Gene Therapy, by Application, Through 2028
• Table 128 : Global Market for Cell and Gene Therapy for Oncology, by Region, Through 2028
• Table 129 : Global Market for Cell and Gene Therapy for Rare Diseases, by Region, Through 2028
• Table 130 : Global Market for Cell and Gene Therapy for Ophthalmology, by Region, Through 2028
• Table 131 : Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, Through 2028
• Table 132 : Global Market for Cell and Gene Therapy, by Region, Through 2028
• Table 133 : North American Market for Cell and Gene Therapy, by Country, Through 2028
• Table 134 : European Market for Cell and Gene Therapy, by Country, Through 2028
• Table 135 : Asia-Pacific Market for Cell and Gene Therapy, by Country, Through 2028
• Table 136 : Global Market for Live Cell Imaging, by Region, Through 2029
• Table 137 : Global Market for Live Cell Imaging, by Components, Through 2029
• Table 138 : Global Market for Live Cell Imaging Instruments and Software, by Region, Through 2029
• Table 139 : Global Market for Live Cell Imaging Consumables, by Region, Through 2029
• Table 140 : Global Market for Live Cell Imaging Services, by Region, Through 2029
• Table 141 : Global Market for Live Cell Imaging, by Technology, Through 2029
• Table 142 : Global Market for Time-Lapse Microscopy, by Region, Through 2029
• Table 143 : Global Market for Fluorescence Resonance Energy Transfer, by Region, Through 2029
• Table 144 : Global Market for Fluorescence Recovery After Photobleaching, by Region, Through 2029
• Table 145 : Global Market for High-Content Screening, by Region, Through 2029
• Table 146 : Global Market for Other Technologies in Live Cell Imaging, by Region, Through 2029
• Table 147 : Global Market for Live Cell Imaging, by End User, Through 2029
• Table 148 : Global Market for Pharmaceutical and Biotechnology Companies Using Live Cell Imaging, by Region, Through 2029
• Table 149 : A Few Academic Research Institute Using Live Cell Imaging Research
• Table 150 : Global Market for Academic Research Institutes Using Live Cell Imaging, by Region, Through 2029
• Table 151 : A Few Contract Research Organizations Using Live Cell Imaging
• Table 152 : Global Market for Contract Research Organizations Using Live Cell Imaging, by Region, Through 2029
• Table 153 : Global Market for Live Cell Imaging, by Region, Through 2029
• Table 154 : North American Market for Live Cell Imaging, by Country, Through 2029
• Table 155 : North American Market for Live Cell Imaging, by Components, Through 2029
• Table 156 : North American Market for Live Cell Imaging, by Technology, Through 2029
• Table 157 : North American Market for Live Cell Imaging, by End User, Through 2029
• Table 158 : U.S. Market for Live Cell Imaging, Through 2029
• Table 159 : Canadian Market for Live Cell Imaging, Through 2029
• Table 160 : Mexican Market for Live Cell Imaging, Through 2029
• Table 161 : European Market for Live Cell Imaging, by Country, Through 2029
• Table 162 : European Market for Live Cell Imaging, by Components, Through 2029
• Table 163 : European Market for Live Cell Imaging, by Technology, Through 2029
• Table 164 : European Market for Live Cell Imaging, by End User, Through 2029
• Table 165 : German Market for Live Cell Imaging, Through 2029
• Table 166 : U.K. Market for Live Cell Imaging, Through 2029
• Table 167 : French Market for Live Cell Imaging, Through 2029
• Table 168 : Spanish Market for Live Cell Imaging, Through 2029
• Table 169 : Italian Market for Live Cell Imaging, Through 2029
• Table 170 : Rest of European Market for Live Cell Imaging, Through 2029
• Table 171 : Asia-Pacific Market for Live Cell Imaging, by Country, Through 2029
• Table 172 : Asia-Pacific Market for Live Cell Imaging, by Components, Through 2029
• Table 173 : Asia-Pacific Market for Live Cell Imaging, by Technology, Through 2029
• Table 174 : Asia-Pacific Market for Live Cell Imaging, by End User, Through 2029
• Table 175 : Chinese Market for Live Cell Imaging, Through 2029
• Table 176 : Japanese Market for Live Cell Imaging, Through 2029
• Table 177 : Indian Market for Live Cell Imaging, Through 2029
• Table 178 : South Korean Market for Live Cell Imaging, Through 2029
• Table 179 : Rest of Asia-Pacific Market for Live Cell Imaging, Through 2029
• Table 180 : Rest of the World Market for Live Cell Imaging, by Components, Through 2029
• Table 181 : Rest of the World Market for Live Cell Imaging, by Technology, Through 2029
• Table 182 : Rest of the World Market for Live Cell Imaging, by End User, Through 2029
• Table 183 : Global Market for Single-Cell Technologies, by Product, Through 2029
• Table 184 : Assay Kits Offered by 10X Genomics
• Table 185 : Global Market for Single-Cell Technologies Consumables, by Region, Through 2029
• Table 186 : Single-Cell Technologies Flow Cytometry Systems, by Company
• Table 187 : Single-Cell Technologies NGS Systems, by Company
• Table 188 : Single-Cell Technologies PCR Systems, by Company
• Table 189 : Single-Cell Technologies Mass Spectrophotometers, by Company
• Table 190 : Single-Cell Technologies Microscopes, by Company
• Table 191 : Global Market for Single-Cell Technologies Instruments, by Region, Through 2029
• Table 192 : Global Market for Single-Cell Technologies, by Cell Type, Through 2029
• Table 193 : Global Market for Single-Cell Technologies in the Human Cells Segment, by Region, Through 2029
• Table 194 : Global Market for Single-Cell Technologies in the Animal Cells Segment, by Region, Through 2029
• Table 195 : Global Market for Single-Cell Technologies in the Microbial Cells Segment, by Region, Through 2029
• Table 196 : Global Market for Single-Cell Technologies, by Technique, Through 2029
• Table 197 : Global Market for Flow Cytometry in Single-Cell Technologies, by Region, Through 2029
• Table 198 : Global Market for Next-Generation Sequencing in Single-Cell Technologies, by Region, Through 2029
• Table 199 : Global Market for Polymerase Chain Reaction in Single-Cell Technologies, by Region, Through 2029
• Table 200 : Global Market for Microscopy in Single-Cell Technologies, by Region, Through 2029
• Table 201 : Global Market for Mass Spectrometry in Single-Cell Technologies, by Region, Through 2029
• Table 202 : Global Market for Other Techniques in Single-Cell Technologies, by Region, Through 2029
• Table 203 : Global Market for Single-Cell Technologies, by Application, Through 2029
• Table 204 : Global Market for Research Applications in Single-Cell Technologies, by Region, Through 2029
• Table 205 : Global Market for Medical Applications of Single-Cell Technologies, by Region, Through 2029
• Table 206 : Global Market for Single-Cell Technologies, by End User, Through 2029
• Table 207 : Global Market for Single-Cell Technologies in Research and Academic Laboratories, by Region, Through 2029
• Table 208 : Global Market for Single-Cell Technologies in Biotechnology and Pharmaceutical Companies, by Region, Through 2029
• Table 209 : Global Market for Single-Cell Technologies in Hospitals and Diagnostic Laboratories, by Region, Through 2029
• Table 210 : Stem Cell Banks and Registries Worldwide, by Country
• Table 211 : Global Market for Single-Cell Technologies in Cell Banks and IVF Centers, by Region, Through 2029
• Table 212 : Global Market for Single-Cell Technologies, by Region, Through 2029

List of Figures

• Figure 1 : Global Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 2 : Global Market for CGT Tools and Reagents, by Region, 2021-2029
• Figure 3 : Market Dynamics of CGT Tools and Reagents
• Figure 4 : CGT Sector Investments, 2018-2023
• Figure 5 : CGT Sector Investments, by Deal Type, Q1 2024
• Figure 6 : Global Market Shares of CGT Tools and Reagents, by Product, 2024
• Figure 7 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
• Figure 8 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
• Figure 9 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
• Figure 10 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
• Figure 11 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
• Figure 12 : Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
• Figure 13 : Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
• Figure 14 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
• Figure 15 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
• Figure 16 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
• Figure 17 : Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
• Figure 18 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
• Figure 19 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
• Figure 20 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
• Figure 21 : Global Market Shares of CGT Tools and Reagents, by Application, 2024
• Figure 22 : Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
• Figure 23 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
• Figure 24 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
• Figure 25 : Global Market Shares of CGT Tools and Reagents, by End User, 2024
• Figure 26 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
• Figure 27 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
• Figure 28 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
• Figure 29 : Global Market Shares of CGT Tools and Reagents, by Region, 2024
• Figure 30 : North American Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 31 : North American Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 32 : North American Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 33 : European Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 34 : European Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 35 : European Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 36 : Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 37 : Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 38 : Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 39 : RoW Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 40 : RoW Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 41 : RoW Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 42 : How a Strong ESG Proposition Benefits Businesses
• Figure 43 : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
• Figure 44 : Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
• Figure 45 : Market Dynamics of Cell Therapy Biomanufacturing
• Figure 46 : Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
• Figure 47 : Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
• Figure 48 : Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
• Figure 49 : North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 50 : European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 51 : Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 52 : RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 53 : Global Market for Gene Synthesis, by Services, 2020-2028
• Figure 54 : Market Dynamics of Gene Synthesis
• Figure 55 : Global Market Shares for Gene Synthesis, by Method, 2022
• Figure 56 : Global Market Shares for Gene Synthesis, by Services, 2022
• Figure 57 : Global Market Shares for Gene Synthesis, by Application, 2022
• Figure 58 : Global Market Shares for Gene Synthesis, by End User, 2022
• Figure 59 : Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
• Figure 60 : Market Dynamics of Global Automated and Closed Cell Therapy Market
• Figure 61 : Global Market Shares of Automated and Closed Cell Therapy, by Automation Type, 2023
• Figure 62 : Global Market for Semi-Automated Cell Therapy, by Region, 2021-2029
• Figure 63 : Global Market for Fully Automated Cell Therapy, by Region, 2021-2029
• Figure 64 : Global Market Shares of Automated and Closed Cell Therapy, by Cell Type, 2023
• Figure 65 : Global Market for Automated and Closed CAR-T Cell Therapy, 2021-2029
• Figure 66 : Global Market for Automated and Closed CAR-T Cell Therapy, by Region, 2021-2029
• Figure 67 : Global Market for Automated and Closed Stem Cell Therapy, 2021-2029
• Figure 68 : Global Market for Automated and Closed Stem Cell Therapy, by Region, 2021-2029
• Figure 69 : Global Market for Automated and Closed Other Cell Therapies, 2021-2029
• Figure 70 : Global Market for Automated and Closed Other Cell Therapies, by Region, 2021-2029
• Figure 71 : Global Market Shares of Automated and Closed Cell Therapy, by Application, 2023
• Figure 72 : Global Market for Clinical Automated and Closed Cell Therapy, 2021-2029
• Figure 73 : Global Market for Commercial Automated and Closed Cell Therapy, 2021-2029
• Figure 74 : Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
• Figure 75 : Global Market for Automated and Closed Cell Therapy, by Region, 2021-2029
• Figure 76 : North American Market Shares of Automated and Closed Cell Therapy, by Country, 2023
• Figure 77 : U.S. Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 78 : Canadian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 79 : Mexican Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 80 : European Market Shares of Automated and Closed Cell Therapy, by Country, 2023
• Figure 81 : German Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 82 : French Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 83 : Italian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 84 : Spanish Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 85 : U.K. Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 86 : Rest of European Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 87 : Asia-Pacific Market Shares of Automated and Closed Cell Therapy, by Country, 2023
• Figure 88 : Chinese Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 89 : Japanese Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 90 : Indian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 91 : Australian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 92 : South Korean Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 93 : Rest of Asia-Pacific Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 94 : Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
• Figure 95 : Cell and Gene Therapy Market Dynamics
• Figure 96 : Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
• Figure 97 : Global Market Shares of Cell and Gene Therapy, by Type of Therapy, 2022
• Figure 98 : Global Market for Cell Therapy, by Region, 2020-2028
• Figure 99 : Global Market for Gene-modified Cell Therapy, by Region, 2020-2028
• Figure 100 : Global Market for Gene Therapy, by Region, 2020-2028
• Figure 101 : Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2020-2028
• Figure 102 : Global Market Shares of Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2022
• Figure 103 : Global Market for AAV Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 104 : Global Market for Retroviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 105 : Global Market for Lentiviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 106 : Global Market for Other Vectors Used in Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 107 : Global Market for Cell and Gene Therapy, by Drug Product, 2020-2028
• Figure 108 : Global Market Shares of Cell and Gene Therapy, by Drug Product, 2022
• Figure 109 : Global Market for Zolgensma for Cell and Gene Therapy, 2020-2028
• Figure 110 : Global Market for Yescarta for Cell and Gene Therapy, 2020-2028
• Figure 111 : Global Market for Kymriah for Cell and Gene Therapy, 2020-2028
• Figure 112 : Global Market for Abecma for Cell and Gene Therapy, 2020-2028
• Figure 113 : Global Market for Maci for Cell and Gene Therapy, 2020-2028
• Figure 114 : Global Market for Tecartus for Cell and Gene Therapy, 2020-2028
• Figure 115 : Global Market for Epicel for Cell and Gene Therapy, 2020-2028
• Figure 116 : Global Market for Other Types of Drugs Used in Drugs Cell and Gene Therapy, 2020-2028
• Figure 117 : Global Market for Cell and Gene Therapy, by Application, 2020-2028
• Figure 118 : Global Market Shares of Cell and Gene Therapy, by Application, 2022
• Figure 119 : Global Market Cell and Gene Therapy for Oncology, by Region, 2020-2028
• Figure 120 : Global Market for Cell and Gene Therapy for Rare Diseases, by Region, 2020-2028
• Figure 121 : Global Market for Cell and Gene Therapy for Ophthalmology, by Region, 2020-2028
• Figure 122 : Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, 2020-2028
• Figure 123 : Global Market for Cell and Gene Therapy, by Region, 2020-2028
• Figure 124 : Global Market Shares of Cell and Gene Therapy, by Region, 2022
• Figure 125 : North American Market Shares of Cell and Gene Therapy, by Country, 2022
• Figure 126 : U.S. Market for Cell and Gene Therapy, 2020-2028
• Figure 127 : Canadian Market for Cell and Gene Therapy, 2020-2028
• Figure 128 : Mexican Market for Cell and Gene Therapy, 2020-2028
• Figure 129 : European Market Shares of Cell and Gene Therapy, by Country, 2022
• Figure 130 : German Market for Cell and Gene Therapy, 2020-2028
• Figure 131 : U.K. Market for Cell and Gene Therapy, 2020-2028
• Figure 132 : French Market for Cell and Gene Therapy, 2020-2028
• Figure 133 : Rest of European Market for Cell and Gene Therapy, 2020-2028
• Figure 134 : Asia-Pacific Market Shares of Cell and Gene Therapy, by Country, 2022
• Figure 135 : Japanese Market for Cell and Gene Therapy, 2020-2028
• Figure 136 : Chinese Market for Cell and Gene Therapy, 2020-2028
• Figure 137 : Australian Market for Cell and Gene Therapy, 2020-2028
• Figure 138 : Rest of Asia-Pacific Market for Cell and Gene Therapy, 2020-2028
• Figure 139 : RoW Market for Cell and Gene Therapy, 2020-2028
• Figure 140 : Global Market for Live Cell Imaging, by Region, 2021-2029
• Figure 141 : Market Dynamics of Global Live Cell Imaging Market
• Figure 142 : Total Stem Cell Research Funding by the National Institutes for Health, 2013-2025
• Figure 143 : Global Market Shares of Live Cell Imaging, by Components, 2023
• Figure 144 : Global Market Shares of Live Cell Imaging, by Technology, 2023
• Figure 145 : Global Market Shares of Live Cell Imaging, by End-user, 2023
• Figure 146 : Global Market Shares of Live Cell Imaging, by Region, 2023
• Figure 147 : North American Market Shares of Live Cell Imaging, by Country, 2023
• Figure 148 : North American Market for Live Cell Imaging, by Components, 2021-2029
• Figure 149 : North American Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 150 : North American Market for Live Cell Imaging, by End User, 2021-2029
• Figure 151 : U.S. Market for Live Cell Imaging, 2021-2029
• Figure 152 : Canadian Market for Live Cell Imaging, 2021-2029
• Figure 153 : Mexican Market for Live Cell Imaging, 2021-2029
• Figure 154 : European Market Shares of Live Cell Imaging, by Country, 2023
• Figure 155 : European Market for Live Cell Imaging, by Components, 2021-2029
• Figure 156 : European Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 157 : European Market for Live Cell Imaging, by End User, 2021-2029
• Figure 158 : German Market for Live Cell Imaging, 2021-2029
• Figure 159 : U.K. Market for Live Cell Imaging, 2021-2029
• Figure 160 : French Market for Live Cell Imaging, 2021-2029
• Figure 161 : Spanish Market for Live Cell Imaging, 2021-2029
• Figure 162 : Italian Market for Live Cell Imaging, 2021-2029
• Figure 163 : Rest of European Market for Live Cell Imaging, 2021-2029
• Figure 164 : Asia-Pacific Market Shares of Live Cell Imaging, by Country, 2023
• Figure 165 : Asia-Pacific Market for Live Cell Imaging, by Components, 2021-2029
• Figure 166 : Asia-Pacific Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 167 : Asia-Pacific Market for Live Cell Imaging, by End User, 2021-2029
• Figure 168 : Chinese Market for Live Cell Imaging, 2021-2029
• Figure 169 : Japanese Market for Live Cell Imaging, 2021-2029
• Figure 170 : Indian Market for Live Cell Imaging, 2021-2029
• Figure 171 : South Korean Market for Live Cell Imaging, 2021-2029
• Figure 172 : Rest of Asia-Pacific Market for Live Cell Imaging, 2021-2029
• Figure 173 : Rest of the World Market for Live Cell Imaging, by Components, 2021-2029
• Figure 174 : Rest of the World Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 175 : Rest of the World Market for Live Cell Imaging, by End User, 2021-2029
• Figure 176 : Global Market for Single-Cell Technologies, by Product, 2021-2029
• Figure 177 : Market Dynamics of Single-Cell Technologies
• Figure 178 : Estimated Numbers of All Cancer Cases, Males and Females (0 to 85+ Years), 2022-2050
• Figure 179 : Personalized Medicine: Growing Share in Total New Molecular Entities (NMEs), 2019-2022
• Figure 180 : Percentage of Deaths from NCDs in Asia-Pacific Countries, 2019
• Figure 181 : Global Market Shares of Single-Cell Technologies, by Product, 2023
• Figure 182 : Global Market Shares of Single-Cell Technologies, by Cell Type, 2023
• Figure 183 : Global Market Shares of Single-Cell Technologies, by Technique, 2023
• Figure 184 : Cost for Sequencing a Human Genome, November 2017-May 2022
• Figure 185 : Global Market Shares of Single-Cell Technologies, by Application, 2023
• Figure 186 : Global Market Shares of Single-Cell Technologies, by End User, 2023
• Figure 187 : Examples of Research and Academic Laboratories Utilizing Single-Cell Technologies
• Figure 188 : Global Market Shares of Single-Cell Technologies, by Region, 2023
• Figure 189 : U.S. NIH Funding for Genome Research, 2021-2023
• Figure 190 : North American Market for Single-Cell Technologies, 2021-2029
• Figure 191 : European Market for Single-Cell Technologies, 2021-2029
• Figure 192 : Asia-Pacific Market for Single-Cell Technologies, 2021-2029
• Figure 193 : Rest of the World Market for Single-Cell Technologies, 2021-2029

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a CAGR of 11.5% during the forecast period of 2024 to 2029.

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a CAGR of 15.8% from 2023 through 2028.

Research Review Scope:

Cell and gene therapy is a vast industry that uses cells and genes in research, development, manufacture, and distribution to treat diseases. Cells and genes can be utilized in preclinical studies, clinical trials, the production of therapies, viral vectors, modified cells, and personalized medicine.

One of the major factors in this market's growth is the increasing investment and funding. The rapid growth in research and development of new cell and gene therapies, along with a new level of innovation, also fuels the growth of this market. However, the high cost of developing these therapies restrains the market's growth.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of Cell and Gene Therapy provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.

This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO208C Cell and Gene Therapy Tools, and Reagents: Global Markets.
• BIO211B Cell Therapy Biomanufacturing: Global Markets.
• BIO251A Gene Synthesis: Technologies and Global Markets.
• BIO258A Global Automated and Closed Cell Therapy Market.
• BIO225B Global Market for Cell and Gene Therapy.
• BIO256A Global Live Cell Imaging Market.
• BIO257A Global Single-cell Technologies Market.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)

• Scope of Report of Cell and Gene Therapy Tools, and Reagents
• Market Summary of Cell and Gene Therapy Tools, and Reagents
• Market Overview of Cell and Gene Therapy Tools, and Reagents
• Approved CGT Products
• Market Dynamics of Cell and Gene Therapy Tools, and Reagents
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Segmentation Analysis of Cell and Gene Therapy Tools, and Reagents
• Segmentation Breakdown of Cell and Gene Therapy Tools, and Reagents
• Global Market for CGT Tools and Reagents, by Product
• Immunoassays
• Bioreactors
• Leukapheresis
• GMP Antibodies
• Multiplex Immunoassays
• Vectors
• Cell Separation
• Cryopreservation
• Cell Expansion
• Media
• GMP Proteins
• GMP Small Molecules
• CRS Monitoring
• Global Market for CGT Tools and Reagents, by Application
• Cancer
• Rare Diseases
• Other Diseases
• Global Market for CGT Tools and Reagents, by End User
• Pharmaceutical and Biotech Companies
• Academic and Research Institutes
• Clinical Laboratories
• Geographic Breakdown
• Global Market for CGT Tools and Reagents, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Emerging Technologies and Developments of Cell and Gene Therapy Tools, and Reagents
• Closed and Automated Systems
• Single-Use Technologies
• Sustainability in the CGT Tool and Reagent Market: ESG Perspective
• Introduction to ESG
• ESG Performance in the Industry
• ESG Practices in the CGT Tool and Reagent Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 3 Cell Therapy Biomanufacturing: Global Markets (BIO211B)

• Scope of Report of Cell Therapy Biomanufacturing
• Market Summary of Cell Therapy Biomanufacturing
• Market Overview of Cell Therapy Biomanufacturing
• Overview
• Market Dynamics of Cell Therapy Biomanufacturing
• Overview
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Segmentation Analysis of Cell Therapy Biomanufacturing
• Key Market Trends
• Cell Therapy Biomanufacturing: Global Markets
• Segmentation Breakdown of Cell Therapy Biomanufacturing
• Market Analysis of Cell Therapy Biomanufacturing, by Product Type
• Market Analysis of Cell Therapy Biomanufacturing, by Application
• Skeletal Muscle Repair
• Bone Repair
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Other Diseases
• Geographic Breakdown of Cell Therapy Biomanufacturing
• Market Analysis of Cell Therapy Biomanufacturing, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 4 Gene Synthesis: Technologies and Global Markets (BIO251A)

• Scope of Report of Gene Synthesis
• Market Summary of Gene Synthesis
• Market Overview of Gene Synthesis
• Overview of Gene Synthesis
• Market Dynamics of Gene Synthesis
• Overview
• Market Drivers
• Restraints
• Opportunities
• Challenges
• Segmentation Breakdown of Gene Synthesis
• Gene Synthesis: Global Market
• Global Market for Gene Synthesis, by Method
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis
• Global Market for Gene Synthesis, by Services
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Other Gene Synthesis Services
• Gene Synthesis: Global Markets, by Application
• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Other Applications
• Global Market for Gene Synthesis, by End User
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Geographic Breakdown of Gene Synthesis
• In-house or Outsource?
• Cost Considerations
• Quality Control and Assurance
• Convenience and Turnaround Time
• Customization and Specialization
• Strategic Considerations
• M&A and Venture Funding of Gene Synthesis
• In Summation

Chapter 5 Global Automated and Closed Cell Therapy Market (BIO258A)

• Scope of Report of Automated and Closed Cell Therapy
• Market Insights of Automated and Closed Cell Therapy
• Market Overview of Automated and Closed Cell Therapy
• Overview
• Market Dynamics of Automated and Closed Cell Therapy
• Market Drivers
• Market Restraints
• Market Opportunities
• Segmentation Breakdown of Automated and Closed Cell Therapy
• Global Automated and Closed Cell Therapy Market by Automation Type
• Semi-Automated Cell Therapy
• Fully Automated Cell Therapy
• Global Automated and Closed Cell Therapy Market by Cell Type
• CAR-T Cells
• Stem Cells
• Other Cell Types
• Global Automated and Closed Cell Therapy Market by Application
• Market Size and Forecast
• Clinical
• Commercial
• Geographic Breakdown of Automated and Closed Cell Therapy
• Global Market for Automated and Closed Cell Therapy by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 6 Global Market for Cell and Gene Therapy (BIO225B)

• Scope of Report of Cell and Gene Therapy
• Market Summary of Cell and Gene Therapy
• Market Value of Cell and Gene Therapy
• Market Overview of Cell and Gene Therapy
• Cell and Gene Therapy Overview
• Market Dynamics of Cell and Gene Therapy
• Market Drivers
• Market Restraints
• Market Opportunities
• Segmentation Breakdown of Cell and Gene Therapy
• Global Market for Cell and Gene Therapy
• Market Analysis
• Cell Therapy
• Market Size and Forecast
• Gene-modified Cell Therapy
• Market Size and Forecast
• Gene Therapy
• Market Forecast
• Vectors Used in Gene-modified Cell Therapy and Gene Therapy
• Market Analysis
• Adeno-Associated Viral Vectors
• Retroviral Vectors
• Lentiviral Vectors
• Other Vectors Used in Gene Therapy
• Market Breakdown by Drug Product
• Zolgensma
• Yescarta
• Kymriah
• Abecma
• Maci
• Tecartus
• Epicel
• Other Drug Products
• Market Breakdown by Application
• Oncology
• Rare Diseases
• Ophthalmology
• Other Therapeutic Areas
• Geographic Breakdown of Cell and Gene Therapy
• Market Breakdown of Cell and Gene Therapy by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Global Live Cell Imaging Market (BIO256A)

• Scope of Report of Live Cell Imaging
• Market Summary of Live Cell Imaging
• Market Overview of Live Cell Imaging
• Overview
• Market Dynamics of Live Cell Imaging
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Segmentation Breakdown of Live Cell Imaging
• Market Segmentation of Live Cell Imaging by Components
• Instruments and Software
• Consumables
• Services
• Market Segmentation of Live Cell Imaging, by Technology
• Time-Lapse Microscopy
• Fluorescence Resonance Energy Transfer (FRET)
• Fluorescence Recovery After Photobleaching (FRAP)
• High-Content Screening (HCS)
• Other Technologies
• Market Segmentation of Live Cell Imaging by End User
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Geographic Breakdown of Live Cell Imaging
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 8 Global Single-cell Technologies Market (BIO257A)

• Scope of Report of Single-cell Technologies
• Market Summary of Single-cell Technologies
• Market Overview of Single-cell Technologies
• Market Dynamics of Single-cell Technologies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Segmentation Breakdown of Single-cell Technologies
• Market Analysis of Single-cell Technologies by Product
• Consumables
• Instruments
• Market Breakdown of Single-cell Technologies by Cell Type
• Human Cells
• Animal Cells
• Microbial Cells
• Market Breakdown by Technique
• Flow Cytometry
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microscopy
• Mass Spectrometry
• Other Techniques
• Market Breakdown of Single-cell Technologies by Application
• Research Applications
• Medical Applications
• Market Breakdown of Single-cell Technologies by End User
• Research and Academic Laboratories
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Laboratories
• Cell Banks and IVF Centers
• Geographic Breakdown of Single-cell Technologies
• Market Analysis by Region of Single-cell Technologies
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 9 Appendix

• Methodology
• Analyst's Credentials